BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Excaliard 



Encinitas  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





 Company News
Excaliard Release: RiverVest Venture Partners Sells Four Successful Life Science Companies for More than $1 Billion 2/7/2012 8:39:13 AM    More...
Pfizer Inc. (PFE) Completes Acquisition of Excaliard 12/2/2011 9:13:34 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) to Receive Up to $14 Million from Pfizer Inc. (PFE) for Its Acquisition of Excaliard 11/22/2011 6:49:36 AM    More...
Excaliard Announces Positive Results From Three Phase 2 Clinical Trials for EXC 001, Showing Significant Improvement in Both Hypertrophic and Fine Line Scarring 1/10/2011 7:25:36 AM    More...
Excaliard Appoints Thomas Wiggans to Chairman of the Board 10/18/2010 7:18:32 AM    More...
Excaliard Announces Positive Data From Phase 2 Clinical Trial of Its Anti-Scarring Drug, EXC 001 8/4/2010 8:42:34 AM    More...
Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001 1/5/2010 11:32:18 AM    More...
Excaliard, an Isis Pharmaceuticals, Inc. (ISIS) (JOBS) Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials 10/29/2009 7:29:52 AM    More...
Excaliard Contracts BioTox Sciences for Preclinical Research Services 11/6/2008 3:06:26 PM    More...
Excaliard Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations 10/10/2008 8:16:40 AM    More...
12

//-->